Fewer than 5 percent of
glioblastoma patients live more than 5 years after being diagnosed.
Not exact matches
Glioblastoma, the most common brain tumor in adults, has no effective long - term treatment and on average,
patients live for 12 to 15 months after diagnosis, according to the National Cancer Institute.
A new population - based study has found that
patients with
glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had
lived significantly longer than
patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer.
While new findings continue to extend the
lives of
patients with
glioblastoma, for the moment, it remains one of the most dreaded diagnoses because despite treatment, GBMs almost always come back, said Bloch.
Glioblastoma multiforme (GBM) is considered the most malignant of primary brain cancers with only about 12 % of
patients living beyond 36 months (long - term survivors).